Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma. [electronic resource]
Producer: 20161213Description: 315-23 p. digitalISSN:- 1747-4094
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bortezomib -- therapeutic use
- Histone Deacetylase Inhibitors -- therapeutic use
- Humans
- Immunologic Factors -- therapeutic use
- Lenalidomide
- Multiple Myeloma -- drug therapy
- Neoplasm Recurrence, Local -- drug therapy
- Proteasome Inhibitors -- therapeutic use
- Salvage Therapy
- Thalidomide -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.